EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network

Jennifer Saliba, Chanez Manseur, Hugo Groult iD, Hussein Akil iD, Mona Tannoury, Danielle Troutaud iD, Thierry Maugard iD, Jean Feuillard, Ingrid Arnaudin, Chantal Jayat-Vignoles

Marine Drugs · 2023

DOI: 10.3390/md21020132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Jennifer Saliba und 9 weiteren Autor:innen. Beteiligte Einrichtung: UMR CNRS 7276, INSERM 1262, CRIBL Laboratory, Faculty of Medecine, Limoges University, 87000 Limoges, France. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue régionale contre le cancer Haute-Vienne France, Ligue Nationale Contre le Cancer and Ligue Régionale Contre le Cancer, Hariri Foundation for Sustainable Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) infects 95% of the world’s population and persists latently in the body. It immortalizes B-cells and is associated with lymphomas. LCLs (lymphoblastoid cell lines, EBV latency III B-cells) inhibit anti-tumoral T-cell response following PD-L1 overexpression (programmed death-ligand 1 immune checkpoint). Many cancer cells, including some DLBCLs (diffuse large B-cell lymphomas), also overexpress PD-L1. Immunotherapies are based on inhibition of PD-L1/PD-1 interactions but present some dose-dependent toxicities. We aim to find new strategies to improve their efficiency by decreasing PD-L1 expression. Fucoidan, a polysaccharide extracted from brown seaweed, exhibits immunomodulatory and anti-tumor activities depending on its polymerization degree, but data are scarce on lymphoma cells or immune checkpoints. LCLs and DLBCLs cells were treated with native fucoidan (Fucus vesiculosus) or original very-low-molecular-weight fucoidan formulas (vLMW-F). We observed cell proliferation decrease and apoptosis induction increase with vLMW-F and no toxicity on normal B- and T-cells. We highlighted a decrease in transcriptional and PD-L1 surface expression, even more efficient for vLMW than native fucoidan. This can be explained by actin network alteration, suggesting lower fusion of secretory vesicles carrying PD-L1 with the plasma membrane. We propose vLMW-F as potential adjuvants to immunotherapy due to their anti-proliferative and proapoptotic effects and ability to decrease PD-L1 membrane expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsLymphoma, Large B-Cell, DiffuseHumansHerpesvirus 4, HumanB7-H1 AntigenActinsPolysaccharides

Stichwörter der Autor:innen

DLBCLsEBV latency III B-cellsPD-L1actin networkfucoidanvery-low-molecular-weight fucoidan

Substanzen

CD274 protein, humanB7-H1 AntigenfucoidanActinsPolysaccharides

Autor:innen und Institutionen

  • UMR CNRS 7276, INSERM 1262, CRIBL Laboratory, Faculty of Medecine, Limoges University, 87000 Limoges, France.
  • UMR CNRS 7266, LIENSs Laboratory, La Rochelle University, 17000 La Rochelle, France.
  • Faculty of Sciences II, Lebanese University, Beirut RGHC+4PR, Lebanon.
  • Hematology Laboratory, CHU Dupuytren, 2 Avenue Martin Luther King, CEDEX 87042 Limoges, France.

ORCID-Profile: Hugo Groult, Hussein Akil, Danielle Troutaud, Thierry Maugard

Förderung

  • Ligue régionale contre le cancer Haute-Vienne France
  • Ligue Nationale Contre le Cancer and Ligue Régionale Contre le Cancer
  • Hariri Foundation for Sustainable Human Development

Zitieren

APA

Saliba, J., Manseur, C., Groult, H., Akil, H., Tannoury, M., Troutaud, D., Maugard, T., Feuillard, J., Arnaudin, I., & Jayat-Vignoles, C. (2023). Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network. Marine Drugs. https://doi.org/10.3390/md21020132

Vancouver

Saliba J, Manseur C, Groult H, Akil H, Tannoury M, Troutaud D, et al. Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network. Marine Drugs. 2023. doi:10.3390/md21020132

BibTeX
@article{Saliba2023,
  author = {Saliba, Jennifer and Manseur, Chanez and Groult, Hugo and Akil, Hussein and Tannoury, Mona and Troutaud, Danielle and Maugard, Thierry and Feuillard, Jean and Arnaudin, Ingrid and Jayat-Vignoles, Chantal},
  title = {Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21020132}
}
Kostenlos starten →